2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-methylpentanoic acid, 95.0%, 2.5g

1-(Bromomethyl)-2-chloro-4-methylbenzene, 98%, 5g

N-benzyltetrahydro-3-thiophenamine 1,1-dioxide hydrochloride, 95.0%, 10g

(1S)-2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diamine, 98%, 5g

Piperidine, PEPTIPURE®, min. 99.5%, for peptide synthesis, 200 ml, glass packaging

Methyl 3-fluoro-4-nitrobenzenecarboxylate, 98%, 1g

3-Fluoro-4-hydroxybenzonitrile, 98.0%, 5g

2-(5-CHLOROBENZOFURAN-3-YL)ETHANAMINE HCL, 95.0%, 250mg

2-Bromo-5-chloro-4-fluoronitrobenzene, 95.0%, 1g

5-Formylthiazole>98.0%(GC)5g

Methyl 2-methyl-2-(4-nitro-1H-imidazol-1-yl)propanoate, 95%, 5g

(R)-3-(((Benzyloxy)carbonyl)amino)-2-methylpropanoic acid, 95%, 100mg

[RuCl(p-cymene)((R)-xylbinap)]Cl200mg